Literature DB >> 11080732

Epidemiologic evidence for asthma and rhinitis comorbidity.

B Leynaert1, F Neukirch, P Demoly, J Bousquet.   

Abstract

Asthma and rhinitis are often comorbid conditions, and the overall characteristics of the diseases and the treatment options for the disorders are similar. Several recent epidemiologic studies in the general population have provided evidence to strongly associate the development of asthma with a previous history of either allergic or perennial rhinitis. Additional links between asthma and rhinitis include a description of increased aspirin intolerance in both disorders and the observation that most subjects with occupational asthma experience rhinitis. Further, the likelihood of the development of asthma is much higher in individuals with both perennial and seasonal rhinitis than for individuals with either condition alone. Asthma and rhinitis were found to be comorbidities regardless of atopic state, and perennial rhinitis has been associated with an increase in nonspecific bronchial hyperresponsiveness. Several studies have identified rhinitis as a risk factor for asthma, with the prevalence of allergic rhinitis in asthmatic patients being 80% to 90%. These studies and others demonstrate that the coexistence of asthma and allergic rhinitis is frequent, that allergic rhinitis usually precedes asthma, and that allergic rhinitis is a risk factor for asthma. Finally, studies that have examined the age of onset of atopy as a confounding factor for the development of asthma and allergic rhinitis have suggested that early age atopy may be an important predictive factor for respiratory symptoms that continue into late childhood. In conclusion, rhinitis and asthma are strongly associated, and rhinitis has been identified as a risk factor for asthma.

Entities:  

Mesh:

Year:  2000        PMID: 11080732     DOI: 10.1067/mai.2000.110151

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  70 in total

1.  Evaluating quality of life in patients with asthma and rhinitis: English adaptation of the rhinasthma questionnaire.

Authors:  Hubert Chen; Miriam G Cisternas; Patricia P Katz; Theodore A Omachi; Laura Trupin; Edward H Yelin; John R Balmes; Paul D Blanc
Journal:  Ann Allergy Asthma Immunol       Date:  2011-01-08       Impact factor: 6.347

2.  Update on prescription and over-the-counter histamine inverse agonists in rhinitis therapy.

Authors:  Lawrence DuBuske; Krzysztof Kowal
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

3.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

Review 4.  Preventing progression of allergic rhinitis to asthma.

Authors:  Jaymin B Morjaria; Massimo Caruso; Emma Rosalia; Cristina Russo; Riccardo Polosa
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

5.  Effect of obesity on sinonasal disease in asthma.

Authors:  S Kanagalingam; S S Shehab; D A Kaminsky; R A Wise; J E Lang; A E Dixon
Journal:  J Asthma       Date:  2017-07-31       Impact factor: 2.515

6.  Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization.

Authors:  Adrian Chan; William Terry; Hongmei Zhang; Wilfried Karmaus; Susan Ewart; John W Holloway; Graham Roberts; Ramesh Kurukulaaratchy; Syed Hasan Arshad
Journal:  Clin Exp Allergy       Date:  2018-02       Impact factor: 5.018

Review 7.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

8.  Relationship between Asthma and Rhinitis: Epidemiologic, Pathophysiologic, and Therapeutic Aspects.

Authors:  Celine Bergeron; Qutayba Hamid
Journal:  Allergy Asthma Clin Immunol       Date:  2005-06-15       Impact factor: 3.406

Review 9.  Breaking patterns of environmentally influenced disease for health risk reduction: immune perspectives.

Authors:  Rodney R Dietert; Jamie C DeWitt; Dori R Germolec; Judith T Zelikoff
Journal:  Environ Health Perspect       Date:  2010-05-18       Impact factor: 9.031

10.  Rhinosinusitis in COPD: symptoms, mucosal changes, nasal lavage cells and eicosanoids.

Authors:  Violetta M Piotrowska; Wojciech J Piotrowski; Zofia Kurmanowska; Jerzy Marczak; Paweł Górski; Adam Antczak
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.